Edwards Lifesciences Corp (EW)vsInteger Holdings Corp (ITGR)
EW
Edwards Lifesciences Corp
$105.80
-0.01%
HEALTHCARE · Cap: $59.81B
ITGR
Integer Holdings Corp
$126.42
-0.21%
HEALTHCARE · Cap: $4.31B
Smart Verdict
WallStSmart Research — data-driven comparison
Edwards Lifesciences Corp generates 266% more annual revenue ($6.67B vs $1.83B). EW leads profitability with a 15.3% profit margin vs 5.7%. EW appears more attractively valued with a PEG of 2.14. EW earns a higher WallStSmart Score of 54/100 (C-).
EW
Buy54
out of 100
Grade: C-
ITGR
Hold41
out of 100
Grade: D
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+69.2%
Fair Value
$257.48
Current Price
$105.80
$151.68 discount
Margin of Safety
+6.6%
Fair Value
$93.36
Current Price
$126.42
$33.06 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Strong operational efficiency at 30.1%
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
Large-cap with strong market position
Reasonable price relative to book value
Areas to Watch
Expensive relative to growth rate
Weak financial health signals
Premium valuation, high expectations priced in
Grey zone — moderate risk
5.7% margin — thin
Weak financial health signals
Expensive relative to growth rate
Comparative Analysis Report
WallStSmart ResearchBull Case : EW
The strongest argument for EW centers on Operating Margin, Debt/Equity, Altman Z-Score. Profitability is solid with margins at 15.3% and operating margin at 30.1%. Revenue growth of 10.5% demonstrates continued momentum.
Bull Case : ITGR
The strongest argument for ITGR centers on Price/Book.
Bear Case : EW
The primary concerns for EW are PEG Ratio, Piotroski F-Score, P/E Ratio. A P/E of 60.5x leaves little room for execution misses.
Bear Case : ITGR
The primary concerns for ITGR are Altman Z-Score, Profit Margin, Piotroski F-Score. A P/E of 42.5x leaves little room for execution misses.
Key Dynamics to Monitor
EW profiles as a mature stock while ITGR is a value play — different risk/reward profiles.
EW carries more volatility with a beta of 0.83 — expect wider price swings.
EW is growing revenue faster at 10.5% — sustainability is the question.
EW generates stronger free cash flow (507M), providing more financial flexibility.
Bottom Line
EW scores higher overall (54/100 vs 41/100), backed by strong 15.3% margins and 10.5% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Edwards Lifesciences Corp
HEALTHCARE · MEDICAL DEVICES · USA
Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring.
Visit Website →Integer Holdings Corp
HEALTHCARE · MEDICAL DEVICES · USA
Integer Holdings Corporation is an outsourced manufacturer of medical devices in the United States, Puerto Rico, Costa Rica, and internationally. The company is headquartered in Plano, Texas.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?